New airway device could make anesthesia safer by allowing easy tube swaps

NCT ID NCT04498598

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a modified supraglottic airway device that lets doctors switch between mask and tube ventilation without using a catheter. The goal is to improve safety during general anesthesia. About 100 adults having planned surgery will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

A/Z modified supraglottic airway device

What this could lead to

If successful, this device could make switching between ventilation modes during anesthesia safer and easier, reducing risks like low oxygen or breathing problems.

What could go wrong

This is a small early-stage study (100 people) testing a device modification. It may not work as intended or may not be safer than current methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypoventilation Hypoxia Respiratory Aspiration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cleveland Clinic Foundation

    RECRUITING

    Cleveland, Ohio, 44195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••